Thursday 21-Nov-2024

Tweet Along With Us

Get ready to follow all the news from AACC and others attending the meeting. Our Twitter hashtag is #2017AACC.

Contact Us

69th AACC Annual Scientific Meeting & Clinical Lab Expo

July 30-August 3

San Diego Convention Center

San Diego, California



Media Contacts:
Molly Polen
Senior Director, Communications & PR
(p) 202.420.7612
(c) 703.598.0472
(JavaScript must be enabled to view this email address)

Christine DeLong
Manager, Communications & PR
(p) 202.835.8722
(c) 443.254.7489
(JavaScript must be enabled to view this email address)

AACC Annual Scientific Meeting Press Room
Room 25A, San Diego Convention Center
(p) 619-525-6215

AACC
900 Seventh St., NW, Suite 400
Washington, DC 20001
(p) 800.892.1400
(f) 202.887.5093

About the Meeting

About the 69th AACC Annual Scientific Meeting & Clinical Lab Expo

The AACC Annual Scientific Meeting offers 5 days packed with opportunities to learn about exciting science from July 30–August 3. Plenary sessions feature the latest research on CRISPR and the future of genome engineering, the public health crisis of antibiotic resistance, treating substance abuse and addiction, preserving fertility in cancer patients, and new frontiers in genomic sequencing.

At the AACC Clinical Lab Expo, more than 750 exhibitors will fill the show floor of the San Diego Convention Center with displays of the latest diagnostic technology, including but not limited to mobile health, molecular diagnostics, mass spectrometry, point-of-care, and automation.

 

Meeting News Releases on Newswise

Reporters: login at top right to access embargoed meeting news releases

A Record-breaking 21,300 Attendees Came to the 69th AACC Annual Scientific Meeting for Its Pioneering Research on CRISPR, Mobile Diagnostics, and Public Health Issues

Attendance at the 69th AACC Annual Scientific Meeting & Clinical Lab Expo reached a record high at this year’s conference in San Diego. Held from July 30-August 3, the meeting featured groundbreaking advances in diagnostic research and technology that will solve a broad range of challenging patient health problems.

–Association for Diagnostic and Laboratory Medicine (ADLM (formerly AACC))|2017-08-03 14:00:45

XIV International Congress of Pediatric Laboratory Medicine - Durban, 20-22 October 2017

/images/uploads/2017/08/2/logopaediatric.png

The XIVth International Congress of Paediatric Laboratory Medicine (ICPLM) and the Task Force on Paediatric Laboratory Medicine (TF-PLM) of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC), invite you to the Congress in Durban, South Africa on October 20-22nd 2017.

– 69th AACC Annual Scientific Meeting Press Program|2017-08-02 20:05:25

XIV International Congress of Pediatric Laboratory Medicine - Durban, 20-22 October 2017

/images/uploads/2017/08/2/logopaediatric.png

The XIVth International Congress of Paediatric Laboratory Medicine (ICPLM) and the Task Force on Paediatric Laboratory Medicine (TF-PLM) of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC), invite you to the Congress in Durban, South Africa on October 20-22nd 2017.

– 69th AACC Annual Scientific Meeting Press Program|2017-08-02 20:05:25

Bio-Rad Launches Recombinant Luteinizing Hormone, Expanding Its Critical Raw Materials Portfolio

Bio-Rad Laboratories, Inc., a global provider of life science research and clinical diagnostic products, announces the launch of recombinant Luteinizing Hormone (LH), which expands the company’s Critical Raw Material offerings.

– 69th AACC Annual Scientific Meeting Press Program|2017-08-02 13:05:17

Research That Could Significantly Improve Treatment for Autism Unveiled at 69th AACC Annual Scientific Meeting

A team of researchers has demonstrated that children with autism spectrum disorder have a unique composition of gut bacteria and urinary metabolites compared with unaffected children. The research, revealed today at the 69th AACC Annual Scientific Meeting & Clinical Lab Expo in San Diego, could lead to promising new treatment options for children with autism as well as earlier detection of the disorder.

– 69th AACC Annual Scientific Meeting Press Program|2017-08-02 09:30:00

Better Outcomes for Young Women Surviving Cancer

Reproductive health is not the same as sex ed,” Teresa K. Woodruff, PhD, from the Feinberg School of Medicine, Northwestern University, reminded us in yesterday’s plenary session, “Oncofertility: From Bench to Bedside to Babies.” The war on cancer has been hard fought, with more young women than ever now surviving cancer but being faced with the possibility of infertility.

– 69th AACC Annual Scientific Meeting Press Program|2017-08-02 03:05:57

New Psychoactive Substances Challenge Detection

Anyone who walked into Monday’s morning symposium, “Novel Psychoactive Substances (NPS) in Emergency Toxicology” thinking that NPS are not a growing threat to public health were quickly disavowed of that notion. Speakers Jennifer Colby, PhD, and Kai Li, MD, described various compounds, including the drug U-47700, which is a synthetic super-opioid that causes extreme euphoria and respiratory depression, frequently leading to adverse effects, including death.

– 69th AACC Annual Scientific Meeting Press Program|2017-08-02 03:05:39

Interesting Findings: Unexpected Discoveries Among the Posters

The 2017 AACC Annual Meeting Organizing Committee accepted 740 abstracts representing innovative scientific work from more than a dozen countries. Although every abstract will not receive distinguished recognition from the AACC Academy or the various AACC Divisions, highlighted here are several interesting studies that you may want to visit during this year’s poster sessions. Posters are located in the upper level of the Sails Pavilion in the San Diego Convention Center.

– 69th AACC Annual Scientific Meeting Press Program|2017-08-02 03:05:24

Expert Advice on Picking the Correct Genetic Test

The amount of information gathered via next-generation sequencing has made the diagnosis of genetic disorders quicker and more accessible to clinicians than ever before, but with expanded testing options come questions about ordering the correct type of testing.

– 69th AACC Annual Scientific Meeting Press Program|2017-08-02 03:05:14

Is Laboratory Medicine Ready for Artificial Intelligence?

Some say that the invention of the abacus more than 2,500 years ago was the first step on the long road to artificial intelligence (AI). The reason why this simple calculator made of beads and wires is often called the precursor to the modern computer is because the principle—performing repeated calculations faster than the human brain—is the same. Now scientists are harnessing the speed of modern computers and programming them with cognitive algorithms and sophisticated decision trees to help solve complex medical problems. This rapidly advancing science was the focus yesterday of the Chair’s Invited Session, “Is Artificial Intelligence in…

– 69th AACC Annual Scientific Meeting Press Program|2017-08-02 03:05:03

IFCC Distinguished Awards 2017!

/images/uploads/2017/08/1/ifcclogo.jpg

The IFCC announces the winners of the eight 2017 IFCC Distinguished Awards. The IFCC Distinguished Awards are bestowed to laboratory medicine professionals to recognize their outstanding achievements, publicize their exceptional research and contributions to medicine and healthcare, and encourage the overall advancement of clinical chemistry and laboratory medicine.

– 69th AACC Annual Scientific Meeting Press Program|2017-08-01 23:05:56

IFCC Worldlab 2017 Durban

/images/uploads/2017/08/2/2017Logo_ICCCLM_Durban.png

WorldLab 2017 promises to be one of the best with a unique blend of innovative science, evidence based laboratory medicine and an emphasis on personalized medicine. This reflects the changing directions of science and medicine with greater attention being paid to prevention and risk stratification.

– 69th AACC Annual Scientific Meeting Press Program|2017-08-01 23:05:16

Two Innovative Methods Could Help to Predict Flu Outbreaks and Prevent the Spread of Antibiotic Resistance

Researchers have discovered new methods that could improve treatment for infectious diseases by enabling earlier detection of influenza outbreaks and curtailing inappropriate antibiotic usage. The findings were presented today at the 69th AACC Annual Scientific Meeting & Clinical Lab Expo in San Diego.

–Association for Diagnostic and Laboratory Medicine (ADLM (formerly AACC))|2017-08-01 14:30:00

Siemens Healthineers to Attract Industry Attention with Atellica Solution 510(k) Clearance and New IT Offerings

Siemens Healthineers will showcase its recently FDA-cleared Atellica Solution and robust IT offerings including Atellica Diagnostics IT for the laboratory and open connectivity solutions for 160+ POCT devices.

– 69th AACC Annual Scientific Meeting Press Program|2017-08-01 12:00:02

Findings That Could Lead to the First Blood Test for Kidney Cancer Presented at the 69th AACC Annual Scientific Meeting

A new study has discovered that two microRNAs could be used to develop the first-ever blood test for kidney cancer as well as novel treatments for this condition. These findings were presented today at the 69th AACC Annual Scientific Meeting & Clinical Lab Expo in San Diego.

–Association for Diagnostic and Laboratory Medicine (ADLM (formerly AACC))|2017-08-01 09:30:00

Novel Studies Deliver Crucial Insight on Opioid and Overall Drug Abuse Trends in U.S., Canada

A new study shows that a change in policy placing more restrictions on all hydrocodone-containing drugs has successfully decreased the use of certain opioids such as Vicodin. This research and a second study illuminating regional drug use trends in Canada were announced today at the 69th AACC Annual Scientific Meeting in San Diego, and could help to guide future strategies for combatting addiction.

– 69th AACC Annual Scientific Meeting Press Program|2017-08-01 09:30:00

Novel Genetic Test Could Help Combat the Opioid Epidemic by Identifying Patients at Risk of Addiction

Researchers have shown that a new genetic test could potentially help stem the tide of the opioid epidemic by predicting which patients are at risk of abusing prescription opioids. These findings were presented for the first time at the 69th AACC Annual Scientific Meeting & Clinical Lab Expo in San Diego.

– 69th AACC Annual Scientific Meeting Press Program|2017-08-01 09:30:00

AACC Announces 2017 Corporate Supporter Award Winners; Thanks Organizations for Their Invaluable Support

AACC is pleased to announce the recipients of the AACC 2017 Top Corporate Supporter Awards. This year, AACC recognizes 46 different companies and organizations that generously support the association through sponsorships, advertising, and exhibiting. These significant contributions make it possible for AACC to improve patient care by fostering research, innovation, and professional excellence in the field of laboratory medicine.

– 69th AACC Annual Scientific Meeting Press Program|2017-08-01 09:00:00

SiO2 Medical Products and Sanaria Sign Agreement for Cryogenic Vials for PfSPZ Vaccine to Prevent Malaria

SiO2 Medical Products, Inc. (“SMP”), a U.S.-based designer, developer, manufacturer, and supplier of pharmaceutical packaging, labware, and consumables products, and Sanaria Inc. (“Sanaria”), a U.S.-based developer, manufacturer, and supplier of vaccines, today announced the signing of an agreement for the development, manufacture, and supply of cryogenic vials for Sanaria’s malaria vaccine, Sanaria® PfSPZ Vaccine.

– 69th AACC Annual Scientific Meeting Press Program|2017-08-01 08:00:15

Breathing Easily with the Hypoxemic Patient

While other molecules may be “sexier,” said John Toffaletti, PhD, a patient with very low oxygen can die within half an hour without appropriate intervention. Toffaletti, together with Craig Rackley, MD, led a popular workshop on Sunday for the third year in a row titled, “Guidance for Evaluating the Hypoxemic Patient in the Critical Care Setting.”

– 69th AACC Annual Scientific Meeting Press Program|2017-08-01 01:05:30

Breathing Easily with the Hypoxemic Patient

While other molecules may be “sexier,” said John Toffaletti, PhD, a patient with very low oxygen can die within half an hour without appropriate intervention. Toffaletti, together with Craig Rackley, MD, led a popular workshop on Sunday for the third year in a row titled, “Guidance for Evaluating the Hypoxemic Patient in the Critical Care Setting.”

– 69th AACC Annual Scientific Meeting Press Program|2017-08-01 01:05:30

Micro-Guests' Role in Pathologic Processes

We host more microbiota than our own cells. These micro-guests produce metabolites that are only beginning to be appreciated as important factors in pathologic processes, from chronic inflammatory diseases to preterm birth. In this morning’s President’s Invited Session, Gary Wu, MD, and Rebecca Simmons, MD, both from the University of Pennsylvania, will share the most recent findings and ongoing trials that are beginning to define the complex host-guest relationship in inflammatory bowel disease (IBD) and pre-term birth.

– 69th AACC Annual Scientific Meeting Press Program|2017-08-01 01:05:24

Micro-Guests' Role in Pathologic Processes

We host more microbiota than our own cells. These micro-guests produce metabolites that are only beginning to be appreciated as important factors in pathologic processes, from chronic inflammatory diseases to preterm birth. In this morning’s President’s Invited Session, Gary Wu, MD, and Rebecca Simmons, MD, both from the University of Pennsylvania, will share the most recent findings and ongoing trials that are beginning to define the complex host-guest relationship in inflammatory bowel disease (IBD) and pre-term birth.

– 69th AACC Annual Scientific Meeting Press Program|2017-08-01 01:05:24

Return of a Classic: Verifying Assay Performance for FDA-Approved Methods

The Phantom of the Opera, the longest-running show in Broadway history with nearly 30 years of continuous production, has captivated generations of fans with its compelling story and soaring score by Andrew Lloyd Weber. Though cut of an entirely different cloth, Sunday mornings’s AACC University course, “Trust But Verify: Getting the Most of Verification Protocols for FDA-Approved Methods”—part of the longest running workshop at the AACC Annual Scientific Meeting—enjoys similar durability and cachet among clinical laboratorians for its enduring relevancy and practicality.

– 69th AACC Annual Scientific Meeting Press Program|2017-08-01 00:05:39

Return of a Classic: Verifying Assay Performance for FDA-Approved Methods

The Phantom of the Opera, the longest-running show in Broadway history with nearly 30 years of continuous production, has captivated generations of fans with its compelling story and soaring score by Andrew Lloyd Weber. Though cut of an entirely different cloth, Sunday mornings’s AACC University course, “Trust But Verify: Getting the Most of Verification Protocols for FDA-Approved Methods”—part of the longest running workshop at the AACC Annual Scientific Meeting—enjoys similar durability and cachet among clinical laboratorians for its enduring relevancy and practicality.

– 69th AACC Annual Scientific Meeting Press Program|2017-08-01 00:05:39

How Powerful is CRISPR?

"Good morning, doctor, I am here for my gene editing appointment.” In the future, could this be a greeting heard in physician offices around the world? With the introduction of CRISPR technology, genetic material can now be more easily and precisely edited, even creating changes that can subsequently be inherited by offspring.

– 69th AACC Annual Scientific Meeting Press Program|2017-08-01 00:05:23

How Powerful is CRISPR?

"Good morning, doctor, I am here for my gene editing appointment.” In the future, could this be a greeting heard in physician offices around the world? With the introduction of CRISPR technology, genetic material can now be more easily and precisely edited, even creating changes that can subsequently be inherited by offspring.

– 69th AACC Annual Scientific Meeting Press Program|2017-08-01 00:05:23

Young Laboratorians Discover Path to Leadership

The path from junior laboratory scientist to senior scientist or director can be daunting. Though a good foundation in scientific knowledge and increasing experience in the day-to-day challenges of the clinical lab help get us there, not many laboratorians have a PhD in leadership. While leadership may not initially seem critical early in your career, seizing opportunities for growth and influence early on can help us be recognized as leaders long before an official title confers it.

– 69th AACC Annual Scientific Meeting Press Program|2017-08-01 00:05:05

Young Laboratorians Discover Path to Leadership

The path from junior laboratory scientist to senior scientist or director can be daunting. Though a good foundation in scientific knowledge and increasing experience in the day-to-day challenges of the clinical lab help get us there, not many laboratorians have a PhD in leadership. While leadership may not initially seem critical early in your career, seizing opportunities for growth and influence early on can help us be recognized as leaders long before an official title confers it.

– 69th AACC Annual Scientific Meeting Press Program|2017-08-01 00:05:05

Ortho Clinical Diagnostics Announces Global Agreement to Make B·R·A·H·M·S PCT Assay Available to Ortho Customers

Ortho Clinical Diagnostics (Ortho), a global leader of in vitro diagnostics, today announced a strategic relationship with B·R·A·H·M·S GmbH, part of Thermo Fisher Scientific Inc., to develop the B·R·A·H·M·S PCT (procalcitonin) assay for use on Ortho’s VITROS® Systems.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-31 11:35:38

Currier Plastics Awarded Patent for Tamper Evident Cap

/images/uploads/2017/07/31/IM0152-TECap_Page_1.jpg

Currier Plastics provides innovative custom molding solutions that create powerful advantages for your business. Our design and engineering expertise combined with the right cost and precise time to market manufacturing provide integrated solutions to improve your business performance.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-31 09:55:36

BioreclamationIVT Expands Biological Sample Portfolio to Support Drug, Diagnostic and Vaccine Development for Five Additional Infectious Diseases

BioreclamationIVT, a leading provider of biospecimens and related services, today announced that it has expanded its infectious disease-state portfolio to include frozen whole blood, plasma and serum samples from patients with HIV-1, HIV-2, dengue, zika and malaria infection.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-31 09:55:11

BioreclamationIVT Expands Biological Sample Portfolio to Support Drug, Diagnostic and Vaccine Development for Five Additional Infectious Diseases

BioreclamationIVT, a leading provider of biospecimens and related services, today announced that it has expanded its infectious disease-state portfolio to include frozen whole blood, plasma and serum samples from patients with HIV-1, HIV-2, dengue, zika and malaria infection.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-31 09:55:11

Precision Pumps Filling Clinical Laboratory Needs

/images/uploads/2017/07/14/PPmoldedbodypic.jpg

Diener Precision Pumps, the leading manufacturer of precision piston pumps and gear pumps announces the introduction of a new enhanced Precision Series piston pump at the AACC this year in San Diego.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-31 08:05:40

DWK Life Sciences Features New Single Source Capabilities for In Vitro Diagnostic (IVD) Kit Production at AACC Annual Meeting

/images/uploads/2017/07/30/IVDgroup.jpg

DWK Life Sciences, having successfully completed the integration of three industry-leading brands into a single, unified international brand, DURAN WHEATON KIMBLE (DWK), is proud to offer the diagnostics industry a convenient, reliable, and complete solution for developing and producing IVD diagnostic kits. Combining our expertise in leak-resistant plastic containers, dropping bottles and closures, diagnostic vials and other innovative packaging solutions with our capabilities in bar coding, particulate cleaning, sterile processing, and an in-house quality control team, DWK Life Sciences offers everything you need to simplify your supply chain for IVD production.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-31 07:30:24

SCIEX Announces the First FDA-Cleared Vitamin D Assay Kit for Mass Spectrometry

/images/uploads/2017/07/28/VitDAssay_Kit_1199_Web_Res.jpg

SCIEX Diagnostics, the in vitro diagnostics division of SCIEX, a global leader in mass spectrometry in the life sciences industry, announced today the first and only FDA-cleared (via the de novo pathway) LC-MS based Vitamin D assay kit, the Vitamin D 200M Assay, exclusively for the SCIEX Topaz™ System

– 69th AACC Annual Scientific Meeting Press Program|2017-07-31 07:00:35

First Fully Integrated LC-MS System for Clinical Diagnostics Announce by SCIEX

/images/uploads/2017/07/28/Topaz_2017_v1.jpg

SCIEX Diagnostics, the in vitro diagnostics division of SCIEX, a global leader in mass spectrometry in the life sciences industry, announced today the launch of the first fully integrated LC-MS system for clinical diagnostics, the SCIEX Topaz™ System.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-31 07:00:21

AACC Launches AACC Middle East in Abu Dhabi

AACC announced today that it will launch a new laboratory medicine conference and expedition next spring – AACC Middle East. AACC Middle East will showcase AACC’s globally-renowned education and scientific programs paired with a dynamic exposition in Abu Dhabi, United Arab Emirates (UAE), March 22-24, 2018.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-30 17:00:00

New Frontiers in Genomic Engineering, Oncofertility, Public Health, and the Digital Health Revolution to Be Explored at the 69th AACC Annual Scientific Meeting

At the 69th AACC Annual Scientific Meeting & Clinical Lab Expo—the premier global conference and exhibit for laboratory medicine—visionaries in the field will illuminate the pioneering research and technology paving the way for better clinical testing and patient care. From July 30–August 3 in San Diego, the meeting will feature more than 200 talks on a broad range of timely healthcare topics. Highlights of these include plenaries that explore transforming biology using CRISPR engineering and new applications for DNA sequencing; preserving fertility in young people with cancer; how clinical testing can help solve public health crises; and a session that…

– 69th AACC Annual Scientific Meeting Press Program|2017-07-30 17:00:00

Winning Star Trek Tricorder Device to Be Presented to Experts at the 69th AACC Annual Scientific Meeting

Press can register here to livestream this special session through Newswise Live on Monday, July 31 at 7:30 PM EDT. The winner of the Qualcomm Tricorder XPRIZE competition will present DxtER—a real-life tricorder—at the 69th AACC Annual Scientific Meeting & Clinical Lab Expo in San Diego. This special session will be the first time that the device is presented to researchers at a U.S. scientific conference.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-30 14:05:32

Ortho Clinical Diagnostics VITROS® NephroCheck® Test for Prediction of Acute Kidney Injury Cleared, Available in Europe

News release from Ortho Clinical Diagnostics regarding CE Mark clearance for VITROS(r) NephroCheck(r)

– 69th AACC Annual Scientific Meeting Press Program|2017-07-28 14:05:11

NEFA Assay

The NEFA assay from Wako Diagnostics is designed to detect a variety of non-esterified fatty acids (NEFA). The test is specific to free fatty acids with minimal interferences from other related compounds and serum components such as bilirubin, hemoglobin, and ascorbic acid. The need for an extraction step has been eliminated. The company’s enzymatic method relies upon the acylation of coenzyme A and ultimately results in a purple colored product that can be measured colorimetrically at 550 nm.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-28 13:45:58

CH50 (Total Complement Activity) Assay

The Autokit CH50 assay from Wako Diagnostics is a fully automated liposome – based assay for the determination of total complement activity in human serum. This proven and widely used methodology can be applied to most automated chemistry analyzers to evaluate deficiency or abnormalities of the complement system. The homogenous size of liposomes gives a stable dispersion. This, along with a fast, 10 minute total reaction time and ease of use makes it the best choice for your lab.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-28 13:35:37

SynAbs Appoints LubBoscience GmbH as New Distributor for Its Unique Catalogue of Monoclonal Antibodies in Switzerland

SynAbs is proud to appoint LuBioSience as its new distributor for Switzerland. LuBioScience has a seasoned team and expertise in selling biochemicals, including the specific monoclonal antibodies of SynAbs, in particular the anti-species which should be welcomed by the Swiss Biopharma R&D and IVD sector.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-28 13:05:56

Ortho Clinical Diagnostics Receives CE Mark for Ortho’s VITROS® Insulin Reagent & Calibrators

RARITAN, N.J. – July 21, 2017 – Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, today announced that Ortho’s VITROS® Immunodiagnostic Products Insulin Reagent and Calibrators have received CE Mark, broadening Ortho’s menu of tests that manage all aspects of diabetes and other pancreatic disorders. An important biomarker in diabetes and pre-diabetes testing, the assay is expected to be commercially available for use on all of Ortho’s VITROS® Immunodiagnostic and Integrated Systems in Europe and other countries accepting the CE Mark during the third quarter of this year. According to the World Health Organization; diabetes affects nine percent…

– 69th AACC Annual Scientific Meeting Press Program|2017-07-28 13:05:44

UNIFLEX- Healthcare Packaging Returns to the AACC Show 2017

Uniflex- Healthcare Packaging, a division of the Uniflex/ S.Walter Packaging company has announced it will be returning to the the AACC 2017 meeting in San Diego, California during July 31-August 3rd, 2017. They will be located at booth 519 at the San Diego Convention Center during the annual meeting. Uniflex has historically been an industry leader and supplier of medical packaging products for 50+ years, and introduced to the market place the liquid-tight adhesive seal specimen bag, the UniVault (R) patient valuables bags, and recently launched its new Lab Shield (R) "Removable-Biohazard" specimen bag. Much excitement surrounds this new product…

– 69th AACC Annual Scientific Meeting Press Program|2017-07-28 13:05:27

Guinea Pig Monoclonal Antibodies : A New Promising Tool for R&D, IVD and Therapeutics

Monoclonal antibodies development has been limited for a long time to only two species : mice and rats. However, the immune systems of mice and rats are not the most suitable in terms of humoral response to certain antigens, such as human antigens like glucagon. Indeed, the protein sequence of glucagon is the same in mice, rats and human (fig. 1). Small not immunogenic antigens, such as antibiotics or toxins, generally failed to trigger an immune response in such species. This is why some companies have developed fusion cell lines to generate monoclonal antibodies in rabbit (Abcam-Epitomics) or in sheep…

– 69th AACC Annual Scientific Meeting Press Program|2017-07-28 13:05:24

Ortho Clinical Diagnostics Receives FDA 510(k) Clearance for Ortho’s VITROS® Insulin Reagent & Calibrators

News about Ortho Clinical Diagnostics' VITROS(r) Insulin Reagent & Calibrators receiving FDA 510(k) clearance

– 69th AACC Annual Scientific Meeting Press Program|2017-07-28 13:05:22

New Antigens and Antibodies for Infectious/Contagious Diseases From the Binding Site

The Immunologicals Group of The Binding Site is pleased to announce the launch of a number of new monoclonal antibodies and recombinant antigens focused on a variety of infectious/contagious disease states – including Cytomegalovirus (CMV), Hepatitis, HIV, Rubella, Syphilis, and Toxoplasmosis.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-28 13:05:20

Staff Icons Works to Improve Industry Staffing Shortage

Dawn Foster, Founder/CEO of Staff Icons, a Global Scientific Recruitment Firm. She brings to the table 25 years of recruiting industry experience. Dawn holds a Bachelor’s Degree in Business Marketing and comes from a family of entrepreneurs. The recruitment niche she tapped into was due to the high demand of Scientists globally and she felt that recruitment services focusing within the scientific arena were much needed. She has built a reputation within the industry as the go-to Recruitment firm for Scientists of all levels. Dawn is passionate about contributing to the industry by finding Scientists career opportunities globally and helping…

– 69th AACC Annual Scientific Meeting Press Program|2017-07-28 11:05:58

New Products for Liquid Biopsy Applications

Liquid biopsy is a new technology for detection and analysis of biomarkers in blood or other body fluids without the need of invasive procedures. One important analyte is cell-free circulating DNA (cfDNA). The main challenges in working with cfDNA are the low concentration (1 - 50 ng/ml) and the high degree of fragmentation of cfDNA (< 500 bp). An additional complication is that the circulating tumor DNA only accounts for up to 20 % of the total cfDNA. Therefore processing higher sample volumes, typically in the range of several milliliters, is required.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-28 11:05:50

Staff Icons Comes to the AACC

As companies and institutions from across the globe converge on San Diego for the annual ACCC meeting there is a common thread between them all – there is a drastic need for more trained professionals.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-28 11:05:22

SynAbs Inks Agreement with Dianova Gmbh as New Distributor for Its Unique Catalogue of Monoclonal Antibodies in Germany

SynAbs is proud to announce strategic deal with successful company Dianova. Dianova has already demonstrated a huge knowledge and expertise in monoclonal antibodies and will consequently extend its catalogue with unique mAbs references from SynAbs. Under the terms of the agreement, Dianova will have access to unique portfolio of rats and guinea pigs mAbs to address German territory needs in R&D and IVD fields.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-28 11:05:12

RD-Biotech Establishes Itself in Monoclonal Antibodies Market

The SME of Besançon bought Diaclone in 2012, then participated in the creation of SynAbs Belgian start-up in 2015. Business is booming.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-28 11:05:02

Diatron to Show Their New Aquila 3-Part Differential Hematology Analyzer at the 2017 AACC Meeting

/images/uploads/2017/07/28/pic.png

The Diatron, global provider of hematology and clinical chemistry analyzers, will display their Aquila 3-part differential hematology analyzer (60 samples /hour throughput) at the upcoming AACC Meeting in San Diego, California on the 1-3 of August, 2017.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-28 11:05:00

Lp-PLA2 Substrate/ Test and VMA Test Are Both Available at SJK!! Come to Visit Our Booth @ 5806!

SJK Global Vanilmandelic Acid (VMA) Assay is a quantitative immunoassay for measuring VMA in human urine.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-28 10:20:07

Ultra-Sensitive C. Difficile Assay In Development By Singulex Demonstrates Potential To Improve Diagnosis In Pilot Studies

Findings presented at the American Society for Microbiology’s ASM Microbe conference show that the ultra-sensitive Clostridium difficile toxin A/B assay in development for use on the Sgx Clarity™ system offers excellent sensitivity and may be a critical tool for improving the diagnosis of this life-threatening infection. The Sgx Clarity system is a fully-automated, in vitro diagnostics platform powered by Single Molecule Counting technology.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-28 10:05:39

Optimize Laboratory Workflow with Yaskawa Motoman Track-Based Specimen Processing Systems

/images/uploads/2017/07/27/Track-BasedSystems.jpg

Yaskawa Motoman offers track-based specimen processing solutions that improve speed, capacity and accuracy for labor-intensive, high throughput areas of the clinical diagnostic lab. These fully integrated pre- and post-analytic automation solutions can enable high throughput with minimal staffing.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-28 10:00:27

First Ultra-Sensitive Cardiac Troponin (cTni) Test Using Single Molecule Counting Technology Receives CE Mark

Singulex, a global immunodiagnostics company pioneering ultra-sensitivity in the precision measurement of protein biomarkers, today announced it has applied the CE Mark to its ultra-sensitive troponin I assay (cTnl), the first offered on the Sgx Clarity® system, a fully-automated, in vitro diagnostics platform powered by Single Molecule Counting technology.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-28 09:15:51

Singulex Announces $50 Million Senior Secured Debt Facility with Perceptive Advisors

Singulex, Inc., the creator of Single Molecule Counting immunodiagnostic technology, announced the closing of a $50 million senior-secured debt facility with Perceptive Advisors. The capital secured will fuel the continued growth of Singulex and its industry-changing Single Molecule Counting platform, which delivers unprecedented ultra-sensitivity and utility to some of the most prevalent and costly diseases.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-28 09:05:53

Singulex Expands Collaboration with European Clinical Laboratories to Demonstrate Applications and Opportunity of Sgx ClarityTM System

Singulex, Inc., the creator of Single Molecule Counting immunodiagnostic technology, is expanding clinical evaluation of the Sgx ClarityTM system at clinical research sites across Europe. With multiple clinical research studies currently underway at a site in Spain and two sites in the United Kingdom, leading researchers and cardiologists across Europe recognize the potential value and utility of the in vitro diagnostics (IVD) platform to help bring greater sensitivity, accuracy and utility to understanding disease status, particularly in heart disease.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-27 15:25:31

PVS 1625 Lab Automation System

The Sarstedt PVS 1625 is a comprehensive, modular laboratory automation system for pre- and post-analytical processing. Independent from an analytical platform, the PVS 1625 is customized per facility needs for any size lab and every need. Modules are available for bulk or rack loading, identification, decapping, sorting, aliquoting, and recapping with either a push or screw cap. Aliquots can be made directly into compatible screw cap tubes and immediately recapped for send-outs or capped post-analysis for archiving. The PVS 1625 is compatible with most analyzer racks and common tube types and dimensions.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-27 15:10:54

Microvette® Capillary Blood Collection Systems

Sarstedt’s Microvette® capillary blood collection systems accommodate volumes of 100µl to 500µl with a choice of two collection techniques.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-27 15:05:49

S-Monovette® Blood Collection System

The Sarstedt S-Monovette® is an innovative, enclosed multiple-sampling blood collection system. Recent studies conclude that the system may be used to significantly reduce hemolysis in blood samples due to shear stress associated with traditional vacuum tubes. Compared to untreated syringes, S-Monovette® tubes contain a range of additives and can be processed directly with no transfer, maintaining a closed connection. Ask how our Point-of-Care solutions can reduce cartridge rejection and limit blood contaminates.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-27 15:05:46

Minivette® POCT

Sarstedt Minivette® POCT devices are designed for the precise and hygienic collection, transfer, and subsequent dispensing of small capillary blood samples for point-of-care tests. Blood is easily collected via capillary action into the collection capillary of the Minivette® POCT. The sample is held securely in the capillary during transfer without spills and then dispensed onto the test field or into a micro tube with a slight push of the opposing integral piston.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-27 15:05:45

High-Speed Closed Tube Sorter HCTS2000 MK2

The Sarstedt HCTS2000 MK2 accessions and sorts closed primary sample tubes rapidly and accurately to 7 user-defined target bins. Optional extension modules add 5 bins each for up to 22 targets. The instrument can process up to 2000 tubes per hour, and tubes can be loaded and unloaded with minimal interruption. Users can select 10 different sets of sorting rules, and the HCTS2000 MK2 can sort with or without LIS connection. It is compatible with a broad range of tubes, regardless of manufacturer.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-27 15:05:15

Roche Launches Cobas® C 513 Analyzer and HbA1c Gen. 3 Assay to Meet Increasing Demand for Testing of People with Diabetes

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that its new dedicated, high-throughput HbA1c testing solution, the cobas c 513 analyzer, and HbA1c Gen. 3 assay has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).

– 69th AACC Annual Scientific Meeting Press Program|2017-07-27 15:05:12

Roche Receives ClLIA Waiver for Cobas® Influenza A/B & RSV Test for the Cobas® Liat®

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the US Food and Drug Administration (FDA) has granted 510(k) clearance and CLIA (Clinical Laboratory Improvement Amendments) waiver for the cobas® Influenza A/B & RSV test for use on the cobas® Liat® System. Roche is the first manufacturer to extend the value of highly accurate CLIA-waived molecular testing beyond flu A/B and strep A to include Respiratory Syncytial Virus (RSV), a cause of more than 80% of acute lower respiratory tract infections in infants under one year of age.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-27 14:35:02

FDA Clears Roche High-Volume Immunoassay Lab Testing Solution to Support Critical Medical Treatment Decisions

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that its new, dedicated high-volume testing immunoassay solution for the cobas 8000 modular analyzer series, the cobas e 801 module, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).

– 69th AACC Annual Scientific Meeting Press Program|2017-07-27 14:30:54

Breakthrough Development for Americans with Suspected Heart Attack – Next Generation Troponin T Test From Roche Cleared by FDA

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it has received the 510(k) clearance for its Elecsys Troponin T Gen 5 STAT (TnT Gen 5 STAT) blood test for patients with a suspected heart attack. With this clearance, Roche is the first IVD company in the U.S. to provide the next generation Troponin testing for patients as an aid in the diagnosis of myocardial infarction, enabling clinicians to more accurately identify patients experiencing a heart attack.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-27 14:30:42

【New Product】Hexokinase (HK)

/images/uploads/2017/07/28/pic1.jpg

Hexokinase (HK, EC 2.7.1.1) is an enzyme that phosphorylates hexoses (six-carbon sugars), forming hexose phosphate. In most organisms, glucose is the most important substrate of hexokinases, and glucose-6-phosphate is the most important product. Hexokinase can transfer an inorganic phosphate group from ATP to a substrate.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-27 13:45:22

IBM and Quest Diagnostics Launch Watson-Powered Genomic Sequencing Service to Help Physicians Bring Precision Cancer Treatments to Patients Nationwide

IBM Watson Health (NYSE: IBM) and Quest Diagnostics (NYSE: DGX) today announced the launch of IBM Watson Genomics from Quest Diagnostics, a new service that helps advance precision medicine by combining cognitive computing with genomic tumor sequencing. Memorial Sloan Kettering Cancer Center (MSK) will supplement Watson’s corpus of scientific data with OncoKB, a precision oncology knowledge base to help inform precision treatment options for cancer patients.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-27 13:05:55

Quest Diagnostics: Harvard Pilgrim Health Care Partners with Physicians to Close Costly Gaps in Care

Harvard Pilgrim Health Care now offers physicians Data Diagnostics®, a point-of-care health analytics technology from Quest Diagnostics (NYSE: DGX) and Inovalon (NASDAQ: INOV) that is designed to help close costly gaps in care and improve health outcomes.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-27 12:40:40

Next Generation of Enzymes for Gene Amplification & Sequencing

In 2016 the team at Pharmozyme made a break through. Developing a proprietary platform, gene amplification enzymes were re-envisioned for the next generation of amplification and sequencing technologies. Taq Polymerase, a major player in biotechnology, was the first product to be produced in Pharmozyme’s new platform.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-27 12:35:53

Information of Products

/images/uploads/2017/07/27/Pic1.png

Proteometech focus on Innovative technology and Novel bio-products. All of our products, Allergy-Q, ImmuneCheck IgG and TriCheck, are world-first products and are being reputed a great success in Korea and the exporting countries.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-27 12:35:01

Quest Diagnostics 50th Anniversary: Celebrating a Half Century of Life-Changing Results

Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, commemorated its 50-year anniversary by awarding $150,000 in total grants to three organizations that share its goal to improve healthcare: The American Red Cross, the National Ovarian Cancer Coalition and Autism Speaks.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-27 12:30:57

Quest Diagnostics Named One of 2017 "World's Most Admired Companies" by Fortune Magazine

Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has been named one of the "World's Most Admired Companies" for 2017 by Fortune.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-27 12:05:03

TriCore Announces David G. Grenache, PhD, as Chief Scientific Officer

TriCore Reference Laboratories announced today that David G. Grenache, PhD; has been selected as its first Chief Scientific Officer, effective September 2017.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-27 12:00:28

Path-Tec: SpectraPath Brings Laboratories into the Future

A pain point many clinical labs will have to tackle in increasing priority over the next few years is cost reduction. As healthcare continues its transition from fee-for-service payments to value-based payments, facilities are anticipating a considerable decrease in Medicare reimbursements for clinical lab tests. With reimbursements shrinking and costs for everything from labor and specimen collection to transportation and logistics rising, labs are challenges to find new and better ways to maintain an acceptable cost structure while delivering the customer service and quality the market demands.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-27 11:55:07

LGC Maine Standards Announces Release of VALIDATE® IBC Linearity and Calibration Verification Test Kit

LGC Maine Standards1 announces the release of VALIDATE® IBC linearity and calibration verification kit. The VALIDATE® IBC kit, in a human serum matrix, evaluates Total Iron Binding Capacity (TIBC) and Unsaturated Iron Binding Capacity (UIBC). Each VALIDATE® IBC kit, prepared using the CLSI EP06-A “equal delta” sample preparation, offers five distinct concentrations covering the reportable range of most chemistry analyzers. Each kit is liquid and ready-to-use. Simply dispense the product from each dropper bottle, directly into five sample cups, and run in replicates.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-27 11:30:42

Auto Chemistry Analyzer-GS200

GS200 is a multi-functional benchtop clinical chemistry analyzer with a throughput up to 150 T/H. It features 24-hour non-stop cooling, stable heating for reaction, bilateral LIS etc., it is a compact chemistry solution for small laboratories and a back-up tool for mid-to-high end laboratories.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-27 11:25:51

Specific Protein Analyzer-PA54

PA54 is a semi-auto analyzer for quantitative determination of specific proteins in blood, urine samples, including HbA1c, HS-CRP, CRP, ASO, CYS-C, RF, mALB, D-Dimer, IgM, IgG, IgA, C3, C4, etc. It's an ideal instrument designed for medium or small labs or backup analyzer in large labs.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-27 11:25:28

Imegen, a Top Spanish Company for Genetic Analysis and Molecular Diagnostics Services and Kits

Imegen is a top Spanish Company for genetic analysis and molecular diagnostics services and kits. We offer A to Z flexible services and products including Sequencing, Arrays, MLPA, Real-time PCR, Digital PCR, NIPT, etc. Our internally developed sequencing technique, NextGeneDx, is based on NGS and differentiates by providing high resolution and coverage >100X of all coding regions of the targeted genes with specificity and robustness comparable to Sanger. Our recently launched Digital PCR kit, QUIMERA, is cutting-edge kit to follow up on transplant patients analysing haematopoietic chimerism. In addition to maximum precision and sensitivity, QUIMERA requires neither standard curves, nor…

– 69th AACC Annual Scientific Meeting Press Program|2017-07-27 11:25:22

New Flow-Tight Liquid Transfer Pump with Linear Drive

KNF introduces the new solenoid-driven FL 10 diaphragm pump for OEM customers. With a nominal liquid flow rate of 100 mL/min, FL 10 features bi-directional flow-tightness without additional check valves, IP 65 protection, simple linear flow rate adjustment, a maintenance-free expected lifetime of 10,000h, and other key cost-saving attributes.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-27 11:25:17

New Ultra-Small, Portable Device Pump

Introducing new KNF NMP 03 micro gas pump—starting at a lightweight 11g and measuring just 12.9 mm wide and 24.2 mm in length—this diminutive pump delivers very consistent, linear transfer from a few milliLiters to 500 mL/min.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-27 11:20:57

Electrolyte Analyze-GE300

GE300 is an easy-to-use, color touch screen electrolyte analyzer with throughput of 60 samples per hour based on ISE method. Auto calibration, sampling, cleaning to assure accurate results. Maintenance-free and long life electrode is another competitive feature to make it stand out and satisfy the customers.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-27 11:05:14

3-Part Auto Hematology Analyzer-KT-6400

KT-6400 is an innovative hematology analyzer with a large touch screen, built-in thermal printer and huge storage capacity. It is a diagnostic system combined with reliable hardware and intuitive software, which is a perfect solution for small labs and clinics.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-27 10:30:33

5-Part Auto Hematology Analyzer-KT-6610

KT-6610 is an innovative, economic, compact hematology analyzer using advanced tri-angle laser scattering, flow cytometry technology to deliver cost-efficient 5-part white blood cell differential results. It is a perfect solution for small labs and clinics, which have limited space and budget, but request accurate hematologic results.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-27 10:20:10

Healthcare’s Most Advanced Upright Refrigerators and Freezers

Follett LLC, an industry leader in medical-grade refrigerators and freezers, announces the release of an enhanced feature set in all of its upright refrigerators and freezers. The new touchscreen control package puts every essential feature at your fingertips – from data collection and alarms, to an electronic locking system.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-27 10:05:42

Ultra-Sensitive Point of Care Test for a Brain Biomarker

Dx-Sys Inc. (Booth # 1356) has developed an ultra-sensitive, Lateral Flow Point of Care diagnostic test for Glial Fibrillary Acidic Protein (GFAP), a potential biomarker for Traumatic Brain Injury (TBI). The test is a one-step quantitative immunochromatographic assay which can be performed in 60 minutes using a Time Resolved Fluorescence Strip Reader with a sensitivity of < 1 pg/mL of GFAP in human serum. The POCT can also be performed on a Qiagen’s standard Fluorescence strip reader for Europium chelates with a sensitivity of 10 pg/mL for GFAP.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-27 09:25:30

Diener Precision Pumps Engineering Your Flow

Diener Precision Pumps, the leading manufacturer of precision piston pumps and gear pumps has been Engineering Your Flow for Clinical Laboratory instruments since 1994. The company prides itself on its Global Engineering of Excellence based in Lodi, CA and its precision manufacturing facility located in Embrach, Swizterland. A perfect marriage of renowned Northern California innovative engineering with Swiss quality produced products.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-27 09:20:15

Biomatrica CE-IVD Marks Blood and Saliva Collection Tubes for Molecular Diagnostics

San Diego biotech announces CE-IVD marking of blood and saliva collection tubes for molecular diagnostics

– 69th AACC Annual Scientific Meeting Press Program|2017-07-27 00:05:53

Ortho Clinical Diagnostics to Present 10 Scientific Posters, Seven Products at AACC

News provided by Ortho Clinical Diagnostics

– 69th AACC Annual Scientific Meeting Press Program|2017-07-26 19:05:13

Diasorin Launches Its New Simplexa C. Difficile Direct Molecular Test in the US Market

DiaSorin (FTSE Italia Mid Cap: DIA) announced today that they have received clearance from the US Food and Drug Administration to market the Simplexa C. difficile Direct Assay for the detection of Clostridium difficile (C. difficile).

– 69th AACC Annual Scientific Meeting Press Program|2017-07-26 15:25:33

Data Innovations® Announces the Launch of Instrument Manager™ v8.15

Data Innovations (DI) today announces the launch of version 8.15 of Instrument Manager (IM), the latest version of the leading middleware product. This version provides technology enhancements to our Hot Backup solution and introduces an additional option called High Availability.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-26 15:20:48

Olympus to Exhibit Imaging Solutions at 69th AACC Annual Scientific Meeting & Clinical Lab Expo

Olympus, a global technology leader in imaging solutions, will have its experts available for product demonstrations at the 69th AACC Annual Scientific Meeting & Clinical Lab Expo July 30 - August 3 in San Diego. The Olympus booth (#3433) will be exhibiting the BX53, BX46, and CX23 microscopes, as well as the DP74. For more information or to schedule an interview and hands-on demonstration with a product expert, please email Kristin Schaeffer at [email protected].

– 69th AACC Annual Scientific Meeting Press Program|2017-07-25 16:05:37

Olympus to Exhibit Imaging Solutions at 69th AACC Annual Scientific Meeting & Clinical Lab Expo

Olympus, a global technology leader in imaging solutions, will have its experts available for product demonstrations at the 69th AACC Annual Scientific Meeting & Clinical Lab Expo July 30 - August 3 in San Diego. The Olympus booth (#3433) will be exhibiting the BX53, BX46, and CX23 microscopes, as well as the DP74. For more information or to schedule an interview and hands-on demonstration with a product expert, please email Kristin Schaeffer at [email protected].

– 69th AACC Annual Scientific Meeting Press Program|2017-07-25 16:05:37

Clippard DR-2 Precision Diaphragm Regulators

When Clippard invented miniature regulators in 1962, the MAR Series became very popular as a simple, robust, and cost-effective regulator in a small package with exceptionally long life. As regulator applications continue to increase, Clippard is meeting the demand with the newest addition to the reputable regulator line. The new DR-2 Series provides greater accuracy and repeatability (±0.15 psi) while maintaining the same flow and performance characteristics as the MAR regulators in a small, sleek package.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-25 15:50:33

Clippard DR-2 Precision Diaphragm Regulators

When Clippard invented miniature regulators in 1962, the MAR Series became very popular as a simple, robust, and cost-effective regulator in a small package with exceptionally long life. As regulator applications continue to increase, Clippard is meeting the demand with the newest addition to the reputable regulator line. The new DR-2 Series provides greater accuracy and repeatability (±0.15 psi) while maintaining the same flow and performance characteristics as the MAR regulators in a small, sleek package.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-25 15:50:33

Bio-Rad Introduces its IH-1000 Blood Typing System for the U.S. Market

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global provider of life science research and clinical diagnostic products, today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) for its IH-1000 blood typing instrument along with approvals for a wide range of associated gel cards and reagents for the U.S. blood typing market. The system offers full automation and walk-away reliability, allowing laboratories to more efficiently manage their blood testing workload.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-25 15:30:34

Bio-Rad Introduces its IH-1000 Blood Typing System for the U.S. Market

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global provider of life science research and clinical diagnostic products, today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) for its IH-1000 blood typing instrument along with approvals for a wide range of associated gel cards and reagents for the U.S. blood typing market. The system offers full automation and walk-away reliability, allowing laboratories to more efficiently manage their blood testing workload.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-25 15:30:34

Bio-Rad Launches Amplichek I Quality Control, the Second in a Series of Controls for the Molecular Diagnostics Testing Market

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global provider of life science research and clinical diagnostic products, today announced its continued expansion into the molecular diagnostics testing market with the launch of Amplichek™ I quality control, which was recently issued a 510(k) clearance from the U.S. Food and Drug Administration (FDA).

– 69th AACC Annual Scientific Meeting Press Program|2017-07-25 15:25:52

Bio-Rad Launches Amplichek I Quality Control, the Second in a Series of Controls for the Molecular Diagnostics Testing Market

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global provider of life science research and clinical diagnostic products, today announced its continued expansion into the molecular diagnostics testing market with the launch of Amplichek™ I quality control, which was recently issued a 510(k) clearance from the U.S. Food and Drug Administration (FDA).

– 69th AACC Annual Scientific Meeting Press Program|2017-07-25 15:25:52

Bio-Rad Announces FDA Clearance of its BioPlex 2200 Syphilis Total & RPR Assay, a Novel Syphilis Testing Method

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global provider of life science research and clinical diagnostic products, today announced it has received U.S. Food and Drug Administration (FDA) clearance for its BioPlex® 2200 Syphilis Total & RPR assay, a novel one-step universal testing method to aid in the diagnosis of syphilis infection.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-25 15:25:22

Bio-Rad Announces FDA Clearance of its BioPlex 2200 Syphilis Total & RPR Assay, a Novel Syphilis Testing Method

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global provider of life science research and clinical diagnostic products, today announced it has received U.S. Food and Drug Administration (FDA) clearance for its BioPlex® 2200 Syphilis Total & RPR assay, a novel one-step universal testing method to aid in the diagnosis of syphilis infection.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-25 15:25:22

Illumina and Bio-Rad Launch Solution for Single-Cell Genomic Sequencing to Enable Robust Study of Complex Diseases

Illumina, Inc. (NASDAQ: ILMN) and Bio Rad Laboratories, Inc. (NYSE: BIO)(NYSE: BIOb) today announced the launch of the Illumina® Bio-Rad® Single-Cell Sequencing Solution at the J.P. Morgan Healthcare Conference, San Francisco. The comprehensive solution is the first next-generation sequencing (NGS) workflow for single-cell analysis, providing researchers the ability to investigate the coordinated contribution of individual cells in tissue function, disease progression, and therapeutic response.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-25 14:55:41

Bio-Rad To Acquire RainDance Technologies and Droplet Intellectual Property

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global provider of life science research and clinical diagnostic products, announced today that it has entered into a definitive agreement to purchase RainDance Technologies, Inc. The terms of the acquisition were not disclosed. Bio-Rad expects the transaction to close during the first quarter of 2017. The company will discuss the acquisition further during Bio-Rad’s upcoming fourth-quarter and full-year 2016 financial results conference call.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-25 14:55:41

Artel Develops New PCS Software to Improve Pipette Calibration Workflow and Operator Assessments

Artel, the technology leader in liquid handling quality assurance, today announced the release of its new PCS® Software. Fully compatible with Artel’s current PCS instruments, the software will also be integrated with the latest generation of the Pipette Calibration System (PCS), to be available late 2016.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-25 14:50:47

AIM LAB to Launch New Compact Pre-Analytical Workstation

At the AACC Expo 2017, the Australian designer and manufacturer of lab automation systems, Aim Lab Automation Technologies Pty Ltd, will unveil its latest PathFinder automation platform – the PathFinder 350D - for automating the de-capping and sorting of incoming blood collection tubes directly into various analyzer racks ready for analysis.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-25 14:35:53

Addcare DNA Extraction Workstation

Based on our proven sample processing technology, Addcare has developed an automated DNA Extraction Workstation, increasing safety and throughput of complex and time consuming preparation of DNA amplification procedures. The system incorporates a high precision 4-channel pipetting system with disposable tips for transfer and mixing of samples and reagents capable of piercing sealed microplates, microplate shaker/incubators to accommodate standard and deep well microplates and cooling modules for PCR tubes and reagent containers. The plate handler transfers plates between processing positions on the platform and a barcode scanner supports sample identification.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-25 14:20:26

Addcare Innovative Technology

Addcare applies state of the state of the art technology, know-how and processes to provide high quality systems which perfectly integrate into your laboratory environment.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-25 14:15:18

Addcare Intelligent Automation Platforms

Addcares liquid handling and assay processing platforms are designed to efficiently automate routine sample preparation, other liquid handling task and a variety of assays in your laboratory. They are an indispensable tool to increase efficiency, throughput and safety in your lab. Lab technicians will be released from time consuming routine and freed capacity will be available for other, valuable tasks.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-25 14:10:16

Addcare AIW ELISA Workstations

Addcare's range of ELISA workstations are designed to increase productivity and quality of immunoassay processing in your lab. They combine all functions required to process microplate based immunoassays on an efficient and flexible platform. A variety of models for small, medium to high throughput sample volumes are designed to perfectly match the needs of your individual lab. Alternative configurations for chemiluminescence and fluorescence immunoassays extend the portfolio. Assay processing is defined and controlled by ADCstation, Addcare's powerful PC-software.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-25 14:05:05

Addcare Fully Automated Blood Grouping System

Addcare fully automated blood grouping system using microcolumn gel card method, simple operation, high sensitivity, can detect low levels of antigen antibody, the results clearly feasible, easy to save, and meet a variety of data management requirements, suitable for large and medium-sized hospitals, blood stations, CDC and other units of the ABO blood type positive and negative type automatic detection, Rh (d) and irregular antibody screening, cross matching, etc. Product details: blood bank system 1 Using Mirocolumn gel card ,results fast and accurate.2. with emergency function, priority processing emergency test .3. wide catch card, catch card is more stable and…

– 69th AACC Annual Scientific Meeting Press Program|2017-07-25 13:55:31

ASCO Announces Rapid Engineered Solutions Program That Delivers Customized Miniature Valve Assemblies within Days

/images/uploads/2017/07/25/ASCORapidEngineeredSolutions_1.jpg

ASCO's Rapid Engineered Solutions program delivers customized miniature valve assemblies in a matter of days to analytical and medical instrument original equipment manufacturing (OEM) customers.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-25 13:05:42

ASCO Announces Rapid Engineered Solutions Program That Delivers Customized Miniature Valve Assemblies within Days

/images/uploads/2017/07/25/ASCORapidEngineeredSolutions_1.jpg

ASCO's Rapid Engineered Solutions program delivers customized miniature valve assemblies in a matter of days to analytical and medical instrument original equipment manufacturing (OEM) customers.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-25 13:05:42

Bio-Rad Announces the Addition of Analytes for Liquichek Tumor Marker Control

Bio-Rad Laboratories, Inc. a global provider of life science research and clinical diagnostic products, today announced the addition of four new analytes to the company’s Liquichek Tumor Marker Control.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-25 13:05:04

Sysmex America, Inc. Announces XN-V Series™ Software for Automated Hematology Analyzer for Scientific Research

Sysmex America introduced the XN-V Series Software for Automated Hematology Analyzers* in the United States and Canada. The XN-V series is the next generation of hematology analyzers geared toward the acceleration of research in the scientific community.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-25 11:40:19

Sysmex America, Inc. Announces XN-V Series™ Software for Automated Hematology Analyzer for Scientific Research

Sysmex America introduced the XN-V Series Software for Automated Hematology Analyzers* in the United States and Canada. The XN-V series is the next generation of hematology analyzers geared toward the acceleration of research in the scientific community.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-25 11:40:19

ERBA Diagnostics, Inc. Appoints David Barka as Interim Chief Executive Officer, Nikhil Vazirani as Member of the Board

ERBA Diagnostics, Inc. (OTC PINK:ERBA) (the “Company”), a fully integrated in vitro diagnostics company, announced today that, effective as of August 1, 2017, David Barka will become the Interim Chief Executive Officer (“CEO”) of the Company and Nikhil Vazirani will join the Board of Directors (the “Board”).

– 69th AACC Annual Scientific Meeting Press Program|2017-07-24 17:00:55

Enabling Your Next Innovation

For more than 65 years, Conductive Technologies Inc., has enabled innovation for Medical Device Manufacturers, Startups, Academia and Foundations. From electrochemical biosensors to printed circuitry, and RFID tags to PTC Heaters, our staff of innovative scientists and engineers assist our customers with depth of knowledge, thorough development and timely delivery.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-24 15:55:45

Enabling Your Next Innovation

For more than 65 years, Conductive Technologies Inc., has enabled innovation for Medical Device Manufacturers, Startups, Academia and Foundations. From electrochemical biosensors to printed circuitry, and RFID tags to PTC Heaters, our staff of innovative scientists and engineers assist our customers with depth of knowledge, thorough development and timely delivery.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-24 15:55:45

Clippard 7 mm 2-Way & 3-Way Normally-Closed Electronic Valves

Clippard's SV series of direct actuating valves offer an extremely fast response time for accurate dosing of minute volumes with the same long life you expect from the original Clippard EV line of valves, now in a 7 mm cartridge package.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-24 15:50:23

Clippard 7 mm 2-Way & 3-Way Normally-Closed Electronic Valves

Clippard's SV series of direct actuating valves offer an extremely fast response time for accurate dosing of minute volumes with the same long life you expect from the original Clippard EV line of valves, now in a 7 mm cartridge package.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-24 15:50:23

Clippard NPV Dual Tube Miniature Solenoid Pinch Valves

Clippard NPV Series Miniature Pinch Valves are solenoid-operated devices designed to open and close tubes for controlling flow of liquids and gases. Other valve types have internal passages that may cause small amounts of fluid to remain in the valve. Pinch valves have no areas or dead volume where fluid can become trapped. Only the inside of the tubing contacts the fluid. Energizing the solenoid retracts or attracts the plunger, which opens or closes the tube. De-energizing the solenoid will allow the plunger to return to its original state.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-24 15:45:51

Clippard NPV Dual Tube Miniature Solenoid Pinch Valves

Clippard NPV Series Miniature Pinch Valves are solenoid-operated devices designed to open and close tubes for controlling flow of liquids and gases. Other valve types have internal passages that may cause small amounts of fluid to remain in the valve. Pinch valves have no areas or dead volume where fluid can become trapped. Only the inside of the tubing contacts the fluid. Energizing the solenoid retracts or attracts the plunger, which opens or closes the tube. De-energizing the solenoid will allow the plunger to return to its original state.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-24 15:45:51

Clippard NPV Series 2-Way Miniature Pinch Valves

The Clippard NPV Series Miniature Pinch Valve is a solenoid-operated device that is designed to open and close tubes for controlling flow of liquids and gases. Other valve types have internal passages that may cause small amounts of fluid to remain in the valve. Pinch valves have no areas or dead volume where fluid can become trapped. Only the inside of the tubing contacts the fluid. Energizing the solenoid retracts or attracts the plunger, which opens or closes the tube. De-energizing the solenoid will allow the plunger to return to its original state.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-24 15:40:23

Clippard NPV Series 2-Way Miniature Pinch Valves

The Clippard NPV Series Miniature Pinch Valve is a solenoid-operated device that is designed to open and close tubes for controlling flow of liquids and gases. Other valve types have internal passages that may cause small amounts of fluid to remain in the valve. Pinch valves have no areas or dead volume where fluid can become trapped. Only the inside of the tubing contacts the fluid. Energizing the solenoid retracts or attracts the plunger, which opens or closes the tube. De-energizing the solenoid will allow the plunger to return to its original state.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-24 15:40:23

Clippard NIV Series PTFE Media Isolation Valves

The Clippard NIV Series Media Isolation Valve is a solenoid-operated device that uses a flexible diaphragm to isolate the actuation mechanism from the fluid path. Media isolation valves are commonly used for a wide variety of applications, including those that require precise, repeatable dispensing of media for analytical instrumentation.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-24 15:30:19

Clippard NIV Series PTFE Media Isolation Valves

The Clippard NIV Series Media Isolation Valve is a solenoid-operated device that uses a flexible diaphragm to isolate the actuation mechanism from the fluid path. Media isolation valves are commonly used for a wide variety of applications, including those that require precise, repeatable dispensing of media for analytical instrumentation.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-24 15:30:19

Accel Biotech Rebrands to XimedicaDx

XimedicaDx, formerly known as Accel Biotech, is proud to unveil their comprehensive rebranding, which is officially being revealed at the 69th AACC Clinical Lab Expo in San Diego. The change comes in alignment with their acquisition by Ximedica, a leading full service medical technologies development firm, in July of 2016. XimedicaDx maintains Accel Biotech’s comprehensive experience and expertise in in-vitro diagnostics and life science product development as Ximedica’s Diagnostics Center of Excellence.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-18 10:35:33

Microscan To Demonstrate Advancements in Barcode and Machine Vision Technology at AACC Clinical Lab Expo 2017

Press Release by Microscan on demonstration of the latest advancements of barcode and machine vision technologies at the AACC Annual Scientific Meeting and Clinical Lab Expo on August 1-3 in San Diego, CA.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-18 06:00:49

Shanghai Ruiyi-Biotech Raw Material and Diagnostic Products R&D Symposium

We would like to introduce you our independently developed instruments, including automatic biochemical analyzer and automatic 6-channel POCT, with supporting reagents in various areas for distribution and OEM

– 69th AACC Annual Scientific Meeting Press Program|2017-07-18 02:05:10

Tosoh Features BIOTIN INTERFERENCE-FREE Immunoassays at AACC 2017

/images/uploads/2017/07/17/tosoh_cs_biosc.jpg

Tosoh Bioscience is proud to showcase Biotin Interference Free immunoassay testing at AACC 2017. Tosoh’s full AIA-PACK® test menu offers a complete line of immunoassay tests that are all free from biotin interference.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-17 19:05:13

JADAK Exhibiting at 2017 American Association for Clinical Chemistry (AACC) Clinical Lab Expo

/images/uploads/2017/07/17/2017-AACC-380x380-Posting-01.png

JADAK, a business unit of Novanta Corporation, is exhibiting at the 69th annual AACC Clinical Lab Expo from August 1st – 3rd, 2017 in San Diego, CA, Booth #2818. JADAK’s exhibit will feature its new Clarity™ 2.0 Machine Vision & Image Analysis Software, demonstrated within a desktop analyzer, as well as its expanded line of Ultra High Frequency (UHF) RAIN RFID products and Near Field Communications (NFC) High Frequency (HF) RFID product line

– 69th AACC Annual Scientific Meeting Press Program|2017-07-17 16:00:31

Abraxis Expands Its Magnetic Beads Offering for Molecular Biology and Sample Prep Applications

/images/uploads/2017/07/17/ABROrangeBeadGraphic2pt3in.jpg

Abraxis, Inc., announces expansion of its AbraMag magnetic beads line for molecular biology, biochemistry and sample prep applications, with the addition of mRNA purification beads and kit.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-17 13:05:11

AACC 2017 to feature plug & play connectivity solution for clinical laboratories with IVD Industry Connectivity Consortium™ LAW™ Profile and LIVD™ specification for digital publication of LOINC to vendor IVD test results

IVD Industry Connectivity Consortium™ (IICC) to present the LIVD specification and IICC/IHE LAW Profile at the 69th AACC Annual Scientific Meeting & Clinical Lab Expo in San Diego, CA

– 69th AACC Annual Scientific Meeting Press Program|2017-07-16 21:05:57

GVS Life Sciences is the Contract Manufacturing Services

GVS Life Sciences is the Contract Manufacturing Services

– 69th AACC Annual Scientific Meeting Press Program|2017-07-14 11:05:05

Sysmex America, Inc. Launches XN-L™ Automated Hematology Analyzers in U.S.

/images/uploads/2017/07/28/XN_350-450-550_left.png

Sysmex America, Inc., a leading provider of automated hematology and urinalysis diagnostic testing equipment as well as middleware information systems technology, today announced that it has launched its XN-L™ automated hematology analyzers in the United States. The new, smaller XN-L line delivers the same globally-proven, clinical and operational value known in its XN-Series™ to lower volume hematology laboratories. The XN-L analyzers will also be the first to feature BeyondCareSM Quality Monitor, a revolutionary approach to quality assurance. ​

–Association for Diagnostic and Laboratory Medicine (ADLM (formerly AACC))|2017-07-11 08:40:43

Innovation in Quality Assurance: New Sysmex BeyondCare Quality Monitor

Sysmex America announced its latest innovation: a way to make quality assurance easier and more risk free than manual quality control processes. “Sysmex is well known for the innovation that it delivers to the laboratory. BeyondCare Quality Monitor elevates quality assurance processes to a new level with automated, continuous monitoring and guidance in an easy-to-use framework,” said Ralph Taylor, chief executive officer.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-11 08:40:33

Innovation in Quality Assurance: New Sysmex BeyondCare Quality Monitor

Sysmex America announced its latest innovation: a way to make quality assurance easier and more risk free than manual quality control processes. “Sysmex is well known for the innovation that it delivers to the laboratory. BeyondCare Quality Monitor elevates quality assurance processes to a new level with automated, continuous monitoring and guidance in an easy-to-use framework,” said Ralph Taylor, chief executive officer.

– 69th AACC Annual Scientific Meeting Press Program|2017-07-11 08:40:33
close
0.38814